As illustrated in Figures 4D,E western blotting analysis and RT-PCR indicated that BJJP reduced the expression of mesenchymal biosignatures containing N-cadherin, Snail and Vimentin (p < 0.05), while it escalated the expression of E-cadherin, an epithelial biosignature (p < 0.05), validating the EMT inhibition effects of BJJP in HCC cells. The gene discussed is SNAI1; the disease is hepatocellular carcinoma.